Posts Tagged: COVID-19
IFI Claims Reports: Patent Activity Increases Despite Pandemic, IBM Again Dominates Granted U.S. Patents, Samsung Leads Global 250
On January 12, patent database provider IFI Claims published its Top 50 U.S. patent grant recipient list for 2020, as well as its Global 250 list of top owners of …
Ready for 2021? Beware Non-Use of Your Trademarks in 2020
Some businesses, as a result of the pandemic, have been pressed to discontinue manufacture or sale of products or have otherwise limited the scope of their business …
How the 2020 Coronavirus Pandemic Changed IP Practice
Greek philosopher Heraclitus is credited with saying “the only thing that is constant is change.” In 2020, life for everyone changed, including for those in the intellectual property (…
Calls for WTO to Suspend IP Rights for Vaccine Innovation Would Jeopardize Incredible Progress
The biggest vaccination effort in the history of medicine is underway to eradicate the global pandemic, with several strong prospects appearing poised for regulatory approval. As of …
Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?
As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the vaccine (messenger RNA, or mRNA) has taken …
Technology-Specific Patent Filing Trends During the Pandemic
The worldwide COVID-19 pandemic has dampened many commercial operations in countries around the world, including the United States. Although the U.S. stock market underwent a historical …
Unexpectedly Active IP Legal Market Bucks Recession Trends and Boosts Outlook
At the onset of the U.S. COVID-19 pandemic in early March 2020, the legal community immediately became concerned about its economic prospects. Particularly in the intellectual property (…
Regeneron, Pfizer and BioNTech Accused of Infringing Allele Patent in Connection with COVID-19 Technologies
Allele Biotechnology and Pharmaceuticals, Inc. (Allele) has accused Regeneron Pharmaceuticals, Inc. (Regeneron); Pfizer, Inc. (Pfizer); and BioNTech SE and BioNTech US, Inc. (collectively BioNTech) for allegedly infringing …
‘Cannibalistic’ Nature of Intellectual Property System Discourages Novel Responses to COVID-19 Management
“The world is unaware of the cannibalistic nature of the current IP system and what it means for innovation and jobs,” Dan Brown, an award-winning inventor (40+ patents) …
Brazilian Ministry of Health Accelerates Examination of Pharma Patent Applications
The Brazilian Patent and Trademark Office (BPTO) presently offers more than 15 programs to speed up examination of patent applications. The prioritization of certain patent applications by means …
Panelists Urge Americans to Trust IP, Trust Vaccines, Listen to Science in COVID-19 Debate
IPWatchdog’s most recent webinar focused on the role of IP in the development of the most promising vaccines to combat COVID-19 and included speakers from the …
Iancu Updates Users on Filing Stats Amid Pandemic During IPO Annual Meeting Address
In his address to the Intellectual Property Owners Virtual Annual Meeting yesterday, USPTO Director Andrei Iancu said that, despite sharp declines in filings and renewals, COVID-19 seems …
United States is Third Again in WIPO Global Innovation Index 2020
Last week, the World Intellectual Property Organization (WIPO) issued the Global Innovation Index (GII) 2020 report jointly with Cornell University, INSEAD and the 2020 GII Knowledge Partners, which included …
A Changing Economy Provides an Opportunity to Reassess Corporate IP Strategy
The current novel coronavirus pandemic and the resulting economic fallout may provide a good opportunity to step back and reevaluate the way companies approach intellectual property. Many …
Protecting COVID-19-Related Software Innovations
The United States Patent and Trademark Office (USPTO) recently announced the COVID-19 Prioritized Examination Pilot Program, under which the USPTO will advance certain patent applications related to …
